BRITTANY JAMES: Open Payments
NPI 1184370892 · CLEMMONS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 76 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $876 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $355 |
| ABBVIE INC. | 14 | $324 |
| Amgen Inc. | 12 | $153 |
| UCB, Inc. | 13 | $141 |
| Janssen Biotech, Inc. | 7 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Lilly USA, LLC | 3 | $63 |
| Genentech USA, Inc. | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
Products named: RINVOQ, Wegovy, Bimzelx, TREMFYA, OTEZLA, Ozempic, ENBREL, Actemra.
Industry payments across NC — which companies pay providers there.
